Literature DB >> 8855012

Prevalence, aetiology and management of heart failure in general practice.

F S Mair1, T S Crowley, P E Bundred.   

Abstract

BACKGROUND: There is a high level of morbidity and mortality among patients with heart failure. Management of the condition has changed substantially in recent years. However, there is little information on the management of heart failure in general practice. AIM: A study was carried out in 1994 to assess the prevalence, aetiology and management of heart failure in a general practice setting.
METHOD: A retrospective review was undertaken of the manual and computerized medical records of patients in two group practices in Liverpool (combined patient population of 17 400).
RESULTS: A total of 266 patients with heart failure were identified (a prevalence of 15 per 1000). The two practices had 2747 patients who were aged 65 years and over and 221 of these had heart failure (prevalence of 80 per 1000). The principal aetiological factor considered responsible for heart failure was: coronary heart disease in 45% of patients, hypertension 18%, valve disease 9%, cor pulmonale 7%, cardiomyopathy 2% and a metabolic problem 2% (aetiology unknown in 17% of cases). Urea and electrolytes had been checked in the last year in 59% of patients. Chest x-ray and electrocardiography had been performed in 89% and 80% of patients, respectively, and echocardiography in 30%. Angiotensin converting enzyme (ACE) inhibitors were being prescribed to 33% of patients.
CONCLUSION: The study found a high prevalence of heart failure among patients aged 65 years and over. Coronary heart disease was considered to be the main aetiological factor. Patients were being investigated mainly by means of chest x-ray and electrocardiography. Most patients with heart failure were not receiving treatment with ACE inhibitors. Evaluation of heart failure by clinical criteria alone is now deemed insufficient. Echocardiography should be used routinely to assess cardiac dysfunction. Patients with confirmed left ventricular dysfunction will benefit from treatment with ACE inhibitors unless contraindications exist. The study suggests that there is a need to explore ways of optimizing the management of patients with heart failure.

Entities:  

Mesh:

Year:  1996        PMID: 8855012      PMCID: PMC1239534     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  10 in total

1.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

Review 2.  Diagnosis and management of heart failure.

Authors:  H J Dargie; J J McMurray
Journal:  BMJ       Date:  1994-01-29

3.  Quality of life in patients with chronic heart failure.

Authors:  K L Grady
Journal:  Crit Care Nurs Clin North Am       Date:  1993-12       Impact factor: 1.326

4.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

5.  Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages.

Authors:  R Pacher; S Globits; J Bergler-Klein; H Teufelsbauer; M Wutte; W Baumgartner; E Ogris; D Glogar
Journal:  Eur Heart J       Date:  1993-02       Impact factor: 29.983

6.  Trends in hospitalization for heart failure in Scotland 1980-1990.

Authors:  J McMurray; T McDonagh; C E Morrison; H J Dargie
Journal:  Eur Heart J       Date:  1993-09       Impact factor: 29.983

7.  Epidemiologic patterns, clinical evaluation, and long-term prognosis in chronic congestive heart failure.

Authors:  J A Franciosa
Journal:  Am J Med       Date:  1986-02-28       Impact factor: 4.965

8.  A large-scale trial of captopril for mild to moderate heart failure in the primary care setting.

Authors:  R DiBianco
Journal:  Clin Cardiol       Date:  1991-08       Impact factor: 2.882

Review 9.  Epidemiological aspects of heart failure.

Authors:  W B Kannel
Journal:  Cardiol Clin       Date:  1989-02       Impact factor: 2.213

10.  Prevalence of heart failure in three general practices in north west London.

Authors:  J Parameshwar; M M Shackell; A Richardson; P A Poole-Wilson; G C Sutton
Journal:  Br J Gen Pract       Date:  1992-07       Impact factor: 5.386

  10 in total
  37 in total

1.  The implementation of evidence-based medicine in general practice prescribing.

Authors:  C Salisbury; N Bosanquet; E Wilkinson; A Bosanquet; J Hasler
Journal:  Br J Gen Pract       Date:  1998-12       Impact factor: 5.386

Review 2.  Heart disease in the elderly.

Authors:  M Lye; C Donnellan
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

3.  The barriers to effective management of heart failure in general practice.

Authors:  J A Hickling; I Nazareth; S Rogers
Journal:  Br J Gen Pract       Date:  2001-08       Impact factor: 5.386

4.  Improving patient outcomes in heart failure: evidence and barriers.

Authors:  J G Cleland
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

Review 5.  Unmet need for diagnosis of heart failure: the view from primary care.

Authors:  F D R Hobbs
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 6.  Contemporary management of heart failure in clinical practice.

Authors:  J G F Cleland
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

7.  Role of the angiotensin II receptor blocker valsartan in heart failure.

Authors:  R L Webb; M de Gasparo
Journal:  Exp Clin Cardiol       Date:  2001

Review 8.  Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis.

Authors:  Clare Davenport; Elaine Yee Lan Cheng; Yip Tung Tony Kwok; Annie Hiu On Lai; Taka Wakabayashi; Chris Hyde; Martin Connock
Journal:  Br J Gen Pract       Date:  2006-01       Impact factor: 5.386

9.  Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.

Authors:  R M Martin; N R Dunn; S N Freemantle; R D Mann
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

10.  Association between left ventricular dysfunction, anemia, and chronic renal failure. Analysis of the Heart Failure Prevalence and Predictors in Turkey (HAPPY) cohort.

Authors:  A Kepez; B Mutlu; M Degertekin; C Erol
Journal:  Herz       Date:  2013-11-13       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.